Funded Startups in Kingston
Across the 8 most recent funded entries, the largest disclosed round is Cyclic Materials’ $75M Series C on 2026-01-23, which is far above the rest of the d…
Across the 8 most recent funded entries, the largest disclosed round is Cyclic Materials’ $75M Series C on 2026-01-23, which is far above the rest of the disclosed amounts (the next-largest disclosed is MindImmune Therapeutics at $5M on 2026-03-10; other disclosed rounds include $1M on 2026-06-03 and $370K on 2026-05-11). The funding dates are also clustered near the top of the list: 4 of 8 rounds were disclosed in 2026 (2026-06-03 through 2026-06-12), while the remaining 4 span 2026-03-10 back to 2021-11-18.
Geographically, the name “Kingston” appears in multiple countries and states: Kingston, Ontario (Kinloch Consulting $30K on 2026-06-12; Focus Graphite $1M on 2026-06-03; mDETECT Inc $370K on 2026-05-11; Cyclic Materials $75M on 2026-01-23), plus Kingston, United States (MindImmune Therapeutics $5M on 2026-03-10), Kingston, Pennsylvania (Edenesque $180K on 2024-04-23), and Kingston, New York (BAKX Therapeutics $25M on 2021-11-18). Stage labeling is uneven: 5 of 8 entries are “Series Unknown,” and 1 entry is explicitly “undisclosed” (SmartTerm on 2023-05-24).
Most recent rounds
8 shownRelated listings
Frequently asked
What stands out in deal size across Kingston, and is there a clear outlier?
Cyclic Materials’ $75M Series C (2026-01-23) dwarfs the rest of the disclosed amounts; the next-largest disclosed round is MindImmune Therapeutics at $5M (2026-03-10), with other disclosed entries ranging from $30K (Kinloch Consulting, 2026-06-12) to $370K (mDETECT Inc, 2026-05-11).
Are the most recent rounds clustered in time, or spread out across years?
The list is front-loaded: 4 of 8 entries are in June 2026 (Kinloch Consulting $30K on 2026-06-12; Focus Graphite $1M on 2026-06-03; and mDETECT Inc $370K on 2026-05-11 is close in the same window), and 2026 accounts for 4 of 8 total rows overall. The oldest disclosed round shown is BAKX Therapeutics’ $25M on 2021-11-18.
How much of the list stays within a single ‘Kingston’ geography, and how fragmented is it?
Multiple ‘Kingston’ locations appear: 4 of 8 rows are tied to Kingston, Ontario (Kinloch Consulting, Focus Graphite, mDETECT Inc, Cyclic Materials). The remaining entries are split across Kingston, United States (MindImmune Therapeutics, $5M on 2026-03-10), Kingston, Pennsylvania (Edenesque, $180K on 2024-04-23), and Kingston, New York (BAKX Therapeutics, $25M on 2021-11-18), plus Kingston, Saint Andrew, Jamaica (SmartTerm, undisclosed on 2023-05-24).
What stage mix dominates this dataset, and how much is missing?
“Series Unknown” appears in 5 of 8 entries, including Kinloch Consulting ($30K on 2026-06-12) and Focus Graphite ($1M on 2026-06-03). One entry is explicitly undisclosed (SmartTerm on 2023-05-24), leaving only Cyclic Materials (Series C, $75M on 2026-01-23), MindImmune Therapeutics (Series Unknown, $5M), Edenesque (Series Unknown), and BAKX Therapeutics (Series A, $25M on 2021-11-18) with a clearer stage label.
Which sectors appear most often, and do they align with the larger checks?
Healthcare/biotech-adjacent coverage is visible through multiple rows: MindImmune Therapeutics (Pharmaceuticals, Biotechnology, Healthcare) at $5M on 2026-03-10 and BAKX Therapeutics (Health Care) at $25M on 2021-11-18. Beyond that, the largest disclosed deal is in Manufacturing (Cyclic Materials, $75M on 2026-01-23), while sectors like Food and Beverage appear in two separate entries (Kinloch Consulting $30K on 2026-06-12 and Edenesque $180K on 2024-04-23).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.